- Home
- LCFY vs MBIO Comparison
LCFY vs MBIO Comparison
Compare LCFY & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- MBIO
- Stock Information
- Founded
- LCFY 2009
- MBIO 2015
- Country
- LCFY Australia
- MBIO United States
- Employees
- LCFY N/A
- MBIO N/A
- Industry
- LCFY
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- MBIO Health Care
- Exchange
- LCFY Nasdaq
- MBIO Nasdaq
- Market Cap
- LCFY 3.7M
- MBIO 4.7M
- IPO Year
- LCFY 2022
- MBIO N/A
- Fundamental
- Price
- LCFY $4.50
- MBIO $2.65
- Analyst Decision
- LCFY
- MBIO
- Analyst Count
- LCFY 0
- MBIO 0
- Target Price
- LCFY N/A
- MBIO N/A
- AVG Volume (30 Days)
- LCFY 5.0M
- MBIO 17.4M
- Earning Date
- LCFY 07-22-2025
- MBIO 08-12-2025
- Dividend Yield
- LCFY N/A
- MBIO N/A
- EPS Growth
- LCFY N/A
- MBIO N/A
- EPS
- LCFY N/A
- MBIO N/A
- Revenue
- LCFY $2,668,385.00
- MBIO N/A
- Revenue This Year
- LCFY N/A
- MBIO N/A
- Revenue Next Year
- LCFY N/A
- MBIO N/A
- P/E Ratio
- LCFY N/A
- MBIO N/A
- Revenue Growth
- LCFY N/A
- MBIO N/A
- 52 Week Low
- LCFY $2.50
- MBIO $0.89
- 52 Week High
- LCFY $13.98
- MBIO $24.00
- Technical
- Relative Strength Index (RSI)
- LCFY 52.74
- MBIO 61.22
- Support Level
- LCFY $4.28
- MBIO $2.62
- Resistance Level
- LCFY $5.40
- MBIO $3.68
- Average True Range (ATR)
- LCFY 1.17
- MBIO 0.59
- MACD
- LCFY 0.08
- MBIO 0.18
- Stochastic Oscillator
- LCFY 20.23
- MBIO 28.77
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.